| Identification | Back Directory | [Name]
Adenosine, 2-amino-2'-deoxy-2'-fluoro-N,2'-dimethyl-, (2'R)- | [CAS]
1998705-62-6 | [Synonyms]
HCV-IN-31
Adenosine, 2-amino-2'-deoxy-2'-fluoro-N,2'-dimethyl-, (2'R)- | [Molecular Formula]
C12H17FN6O3 | [MDL Number]
MFCD34179522 | [MOL File]
1998705-62-6.mol | [Molecular Weight]
312.3 |
| Chemical Properties | Back Directory | [storage temp. ]
4°C, protect from light | [solubility ]
DMSO : 100 mg/mL (320.20 mM; Need ultrasonic) | [form ]
A solid | [color ]
White to off-white |
| Hazard Information | Back Directory | [Uses]
HCV-IN-31 (compound 4) is a HCV inhibitor, with an EC50/EC95 of 15.7 μM for HCV replicon[1]. | [Biological Activity]
HCV-IN-31 (compound 4) is a HCV inhibitor, with an EC50/EC95 of 15.7 μM for HCV replicon[1]. | [References]
[1]. Jean-Pierre Sommadossi, et al. BETA-D-2-DEOXY-2-ALPHA-FLUORO-2- BETA-C-SUBSTITUTED-2-MODIFIED N6-SUBSTITUTED PURINE NUCLEOTDES FORHCV TREATMENT. US20160257706A1. |
|
|